{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:21:44Z","timestamp":1778858504803,"version":"3.51.4"},"reference-count":46,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2021,9,7]],"date-time":"2021-09-07T00:00:00Z","timestamp":1630972800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Huntington's Disease"],"published-print":{"date-parts":[[2021,9,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Huntington\u2019s disease (HD) is a rare, genetic, neurodegenerative disease. Obtaining population-level data on epidemiology and disease management is challenging.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>To investigate the epidemiology, clinical manifestations, treatment, and healthcare utilization of patients with HD in Israel.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Retrospective population-based cohort study, including 20 years of routinely collected data from Maccabi Healthcare Services, an insurer and healthcare provider for one-quarter of the Israeli population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The study cohort included 109 adult patients (aged \u226518 years) diagnosed with HD, with mean age of 49.9 years and 56%females. The most common HD-related conditions were anxiety (40%), behavioral problems (34%), sleep disorders (21%), and falls (13%). Annual incidence rates for HD ranged from 0.17 to 1.34 per 100,000 from 2000 to 2018; the 2018 crude prevalence in adults was 4.36 per 100,000. Median survival from diagnosis was approximately 12 years (95%CI: 10.4\u201315.3). The most frequent symptomatic treatments were antidepressants (69%), antipsychotics (63%), and tetrabenazine (63%), the only drug approved for the treatment of HD chorea in Israel during the examined period. Patterns of healthcare utilization changed as disease duration increased, reflected by increased frequency of emergency department visits and home visits.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>This retrospective population-based study provides insights into the prevalence, incidence, clinical profile, survival, and resource utilization of patients with HD in ethnically diverse Israel. The findings in this study are generally consistent with the international literature and demonstrate the value of routinely collected healthcare data as a complementary resource in HD research.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3233\/jhd-210500","type":"journal-article","created":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T17:43:18Z","timestamp":1632850998000},"page":"469-477","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":13,"title":["Huntington\u2019s Disease in Israel: A Population-Based Study Using 20 Years of Routinely-Collected Healthcare Data"],"prefix":"10.1177","volume":"10","author":[{"given":"Natalie","family":"Gavrielov-Yusim","sequence":"first","affiliation":[{"name":"Product Development Personalized Health Care \u2013 Data Science, Roche Pharmaceuticals, Hod HaSharon, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yael","family":"Barer","sequence":"additional","affiliation":[{"name":"Maccabitech Institute for Research and Innovation, Maccabi Healthcare Services, Tel Aviv, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Martinec","sequence":"additional","affiliation":[{"name":"Product Development Personalized Health Care \u2013 Data Science, F. Hoffmann-La Roche Ltd., Basel, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athanasios","family":"Siadimas","sequence":"additional","affiliation":[{"name":"Product Development Personalized Health Care \u2013 Data Science, F. Hoffmann-La Roche Ltd., Basel, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Spyros","family":"Roumpanis","sequence":"additional","affiliation":[{"name":"Product Development Personalized Health Care \u2013 Data Science, F. Hoffmann-La Roche Ltd., Basel, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah","family":"Furby","sequence":"additional","affiliation":[{"name":"Product Development Personalized Health Care \u2013 Data Science, Roche, Welwyn, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inbal","family":"Goldshtein","sequence":"additional","affiliation":[{"name":"Maccabitech Institute for Research and Innovation, Maccabi Healthcare Services, Tel Aviv, Israel"},{"name":"Department of Epidemiology and Preventive Medicine, School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asif","family":"Jan","sequence":"additional","affiliation":[{"name":"Product Development Personalized Health Care \u2013 Data Science, F. Hoffmann-La Roche Ltd., Basel, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Preciosa M.","family":"Coloma","sequence":"additional","affiliation":[{"name":"Product Development Personalized Health Care \u2013 Data Science, F. Hoffmann-La Roche Ltd., Basel, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2021,9,25]]},"reference":[{"key":"ref001","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(93)90585-E"},{"key":"ref002","doi-asserted-by":"publisher","DOI":"10.1038\/ng0893-387"},{"key":"ref003","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-5-40"},{"key":"ref004","doi-asserted-by":"publisher","DOI":"10.1111\/ene.13413"},{"key":"ref005","doi-asserted-by":"publisher","DOI":"10.3111\/13696998.2013.818545"},{"key":"ref006","doi-asserted-by":"publisher","DOI":"10.1111\/ene.13107"},{"key":"ref007","doi-asserted-by":"publisher","DOI":"10.1371\/currents.RRN1206"},{"key":"ref008","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.00710"},{"key":"ref009","doi-asserted-by":"publisher","DOI":"10.1002\/mds.25075"},{"key":"ref010","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27653"},{"key":"ref011","doi-asserted-by":"publisher","DOI":"10.4103\/0366-6999.159359"},{"key":"ref012","doi-asserted-by":"publisher","DOI":"10.2217\/nmt-2016-0008"},{"key":"ref013","doi-asserted-by":"publisher","DOI":"10.1002\/mdc3.12388"},{"key":"ref014","unstructured":"Enroll-HD A worldwide observational study for Huntington\u2019s disease families [accessed May 11 2021]. Available from: https:\/\/enroll-hd.org\/."},{"key":"ref015","doi-asserted-by":"publisher","DOI":"10.1111\/cge.12344"},{"key":"ref016","doi-asserted-by":"publisher","DOI":"10.1159\/000479375"},{"key":"ref017","unstructured":"CohenR, DamariN Membership in Sick Funds 2017 [in Hebrew] [accessed May 11 2021]. Available from: https:\/\/www.btl.gov.il\/Publications\/survey\/Documents\/seker303.pdf."},{"key":"ref018","doi-asserted-by":"publisher","DOI":"10.1097\/01.mlr.0000207817.32496.cb"},{"key":"ref019","first-page":"1353","volume":"9","author":"Hurtado-Navarro I","year":"2018","journal-title":"A real-world study with atrial fibrillation patients treated with oral anticoagulants in Spain. Front Pharmacol"},{"key":"ref020","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-4356(96)00268-5"},{"key":"ref021","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1326"},{"key":"ref022","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-801893-4.00003-1"},{"key":"ref023","doi-asserted-by":"publisher","DOI":"10.1159\/000443738"},{"key":"ref024","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-019-1556-3"},{"key":"ref025","doi-asserted-by":"publisher","DOI":"10.1111\/cge.13168"},{"key":"ref026","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-009070"},{"key":"ref027","doi-asserted-by":"publisher","DOI":"10.1159\/000479697"},{"key":"ref028","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(10)70245-3"},{"key":"ref029","doi-asserted-by":"publisher","DOI":"10.1002\/mdc3.12502"},{"key":"ref030","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.56.1.98"},{"key":"ref031","doi-asserted-by":"publisher","DOI":"10.1017\/S0317167100012671"},{"key":"ref032","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.66.1.52"},{"key":"ref033","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-019-4806-6"},{"key":"ref034","doi-asserted-by":"publisher","DOI":"10.14802\/jmd.14038"},{"key":"ref035","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0029522"},{"key":"ref036","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70238-8"},{"key":"ref037","doi-asserted-by":"publisher","DOI":"10.1038\/ejhg.2016.36"},{"key":"ref038","doi-asserted-by":"publisher","DOI":"10.1176\/jnp.2007.19.4.441"},{"key":"ref039","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-444-63916-5.00016-1"},{"key":"ref040","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22003"},{"key":"ref041","first-page":"118","volume":"51","author":"Blumstein T","year":"2014","journal-title":"Israel J Psychiatry Relat Sci"},{"key":"ref042","doi-asserted-by":"publisher","DOI":"10.4088\/PCC.v09n0504"},{"key":"ref043","doi-asserted-by":"publisher","DOI":"10.1002\/mdc3.12376"},{"key":"ref044","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870110204"},{"key":"ref045","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-015-7900-7"},{"key":"ref046","doi-asserted-by":"publisher","DOI":"10.36469\/9779"}],"container-title":["Journal of Huntington's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.3233\/JHD-210500","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.3233\/JHD-210500","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.3233\/JHD-210500","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T08:56:03Z","timestamp":1777452963000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.3233\/JHD-210500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,7]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,9,7]]}},"alternative-id":["10.3233\/JHD-210500"],"URL":"https:\/\/doi.org\/10.3233\/jhd-210500","relation":{},"ISSN":["1879-6397","1879-6400"],"issn-type":[{"value":"1879-6397","type":"print"},{"value":"1879-6400","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,7]]}}}